Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C): Results From a Multicenter Phase III Study

Faculty Opinions recommendation of Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725906524.793510948 ◽

2015 ◽

Author(s):

Paul Van Schil

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Stage Iiia ◽

Reply to the article “Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study”, by Groen et al. (Ann Oncol 2004; 15: 427–432)

Annals of Oncology ◽

10.1093/annonc/mdh323 ◽

2004 ◽

Vol 15 (8) ◽

pp. 1298-1299

Author(s):

B. Jeremic

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Multicenter Phase ◽

Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study

Annals of Oncology ◽

10.1093/annonc/mdh100 ◽

2004 ◽

Vol 15 (3) ◽

pp. 427-432 ◽

Cited By ~ 47

Author(s):

H.J.M. Groen ◽

A.H.W. van der Leest ◽

E. Fokkema ◽

P.R. Timmer ◽

G.D. Nossent ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Multicenter Phase ◽

A phase III study of Æ-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell Lung cancer (NSCLC) (NCI T99–0046, RTOG 02–70, MDA 99–303): An interim report of toxicity and response

10.1200/jco.2005.23.16_suppl.7144 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7144-7144 ◽

Cited By ~ 7

Author(s):

C. Lu ◽

R. Komaki ◽

R. S. Herbst ◽

W. K. Evans ◽

J. J. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Interim Report ◽

Small Cell Lung ◽

Concomitant Chemoradiotherapy ◽

Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE).

10.1200/jco.2014.32.15_suppl.7510 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7510-7510 ◽

Cited By ~ 1

Author(s):

Wilfried Ernst Erich Eberhardt ◽

Thomas Christoph Gauler ◽

Christoph Pöttgen ◽

Godehard Friedel ◽

Stefanie Veit ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Stage Iiia ◽

Concomitant Chemotherapy and IFN-alpha for Small Cell Lung Cancer: A Randomized Multicenter Phase III Study

Journal of Interferon & Cytokine Research ◽

10.1089/107999099314180 ◽

1999 ◽

Vol 19 (3) ◽

pp. 253-259 ◽

Cited By ~ 23

Author(s):

Tarja M. Ruotsalainen ◽

Maija Halme ◽

Klaus Tamminen ◽

Janusz Szopinski ◽

Aila Niiranen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Concomitant Chemotherapy ◽

Small Cell Lung ◽

Ifn Alpha ◽

Multicenter Phase ◽

S-1 Plus Cisplatin Versus Docetaxel Plus Cisplatin in Chemotherapy-Naive Patients with Advanced Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase III Study (TCOG0701)

Annals of Oncology ◽

10.1016/s0923-7534(20)32012-3 ◽

2012 ◽

Vol 23 ◽

pp. xi34

Author(s):

S. Niho ◽

A. Gemma ◽

H. Sakai ◽

K. Kubota ◽

M. Nishio ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Multicenter Phase ◽

Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non–small cell lung cancer: Results from a multicenter phase III study

Journal of Thoracic and Cardiovascular Surgery ◽

10.1016/j.jtcvs.2011.07.051 ◽

2011 ◽

Vol 142 (5) ◽

pp. 1143-1151 ◽

Cited By ~ 47

Author(s):

Hiran C. Fernando ◽

Rodney J. Landreneau ◽

Sumithra J. Mandrekar ◽

Shauna L. Hillman ◽

Francis C. Nichols ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Sublobar Resection ◽

Small Cell Lung ◽

Multicenter Phase ◽

Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309)

10.1200/jco.2005.23.16_suppl.7014 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7014-7014 ◽

Cited By ~ 122

Author(s):

K. S. Albain ◽

R. S. Swann ◽

V. R. Rusch ◽

A. T. Turrisi ◽

F. A. Shepherd ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Surgical Resection ◽

Cell Lung Cancer ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Stage Iiia ◽

An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer.

10.1200/jco.2015.33.15_suppl.8039 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8039-8039 ◽

Cited By ~ 2

Author(s):

Jianxing He ◽

Yuankai Shi ◽

Jianhua Chang ◽

Mengzhao Wang ◽

Baohui Han ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Open Label ◽

Multicenter Phase ◽